CNR President Maria Chiara Carrozza visits HT
Today CNR President Maria Chiara Carrozza visited Human Technopole headquarters together with a delegation of department and institute directors of the National Research Council. HT Director Iain Mattaj and HT President Marco Simoni were joined at the meeting by representatives of the institute’s research areas who gave President Carrozza a tour of Human Technopole’s first laboratory spaces.
“We are very pleased to welcome to Palazzo Italia the newly appointed CNR President Maria Chiara Carrozza. Since its very early stages, Human Technopole has initiated a dialogue with representatives of the national scientific community to build a collaborative network and bring added value to an already thriving research ecosystem. We share with CNR our commitment to scientific excellence, an open and international approach and our goal of training the next generation of scientists” stated prof. Mattaj.
President Carrozza underlined, “I am happy to have met, together with the directors of Cnr, the top management and colleagues of Human Technopole and to have visited their headquarters. It was an informal, simple and friendly visit, in the spirit of a meeting between researchers, but important to prepare ourselves for the challenges we will face post-pandemic, starting from ecological transition, digital transformation and health. Challenges in which the contribution of research, and particularly biomedical research, is fundamental “.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.